|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 6 (September 15), 1998:
pp. 1989-2002
Saturation Mutagenesis of the Subunit of the Human
Granulocyte-Macrophage Colony-Stimulating Factor Receptor Shows
Clustering of Constitutive Mutations, Activation of ERK MAP Kinase and
STAT Pathways, and Differential Subunit Tyrosine
Phosphorylation
Brendan J. Jenkins,
Timothy J. Blake, and
Thomas J. Gonda
From the Hanson Centre for Cancer Research and Division of Human
Immunology, Institute of Medical and Veterinary Science, Adelaide,
South Australia, Australia.
The high-affinity receptors for human granulocyte-macrophage
colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 are
heterodimeric complexes consisting of cytokine-specific subunits
and a common signal-transducing subunit (h c). We have previously
demonstrated the oncogenic potential of this group of receptors by
identifying constitutively activating point mutations in the
extracellular and transmembrane domains of h c. We report here a
comprehensive screen of the entire h c molecule that has led to the
identification of additional constitutive point mutations by virtue of
their ability to confer factor independence on murine FDC-P1 cells.
These mutations were clustered exclusively in a central region of h c
that encompasses the extracellular membrane-proximal domain,
transmembrane domain, and membrane-proximal region of the cytoplasmic
domain. Interestingly, most h c mutants exhibited cell type-specific
constitutive activity, with only two transmembrane domain mutants able
to confer factor independence on both murine FDC-P1 and BAF-B03 cells.
Examination of the biochemical properties of these mutants in FDC-P1
cells indicated that MAP kinase (ERK1/2), STAT, and JAK2 signaling
molecules were constitutively activated. In contrast, only some of the
mutant subunits were constitutively tyrosine phosphorylated. Taken
together, these results highlight key regions involved in h c
activation, dissociate h c tyrosine phosphorylation from MAP kinase
and STAT activation, and suggest the involvement of distinct mechanisms
by which proliferative signals can be generated by h c.
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. L. Brown, C. R. Wilkinson, S. R. Waterman, C. H. Kok, D. G. Salerno, S. M. Diakiw, B. Reynolds, H. S. Scott, A. Tsykin, G. F. Glonek, et al.
Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling
J. Leukoc. Biol.,
August 1, 2006;
80(2):
433 - 447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Brown, M. Peters, R. J. D'Andrea, and T. J. Gonda
Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation
Blood,
January 15, 2004;
103(2):
507 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. T. Phan, D. B. Shultz, B.-T. H. Truong, T. J. Blake, A. L. Brown, T. J. Gonda, M. M. Le Beau, and S. C. Kogan
Cooperation of Cytokine Signaling with Chimeric Transcription Factors in Leukemogenesis: PML-Retinoic Acid Receptor Alpha Blocks Growth Factor-Mediated Differentiation
Mol. Cell. Biol.,
July 1, 2003;
23(13):
4573 - 4585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Blake, B. J. Jenkins, R. J. D'Andrea, and T. J. Gonda
Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the {beta}-subunit of the GM-CSF receptor
J. Leukoc. Biol.,
December 1, 2002;
72(6):
1246 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Le, F. Stomski, J. M. Woodcock, A. F. Lopez, and T. J. Gonda
The Role of Disulfide-linked Dimerization in Interleukin-3 Receptor Signaling and Biological Activity
J. Biol. Chem.,
February 18, 2000;
275(7):
5124 - 5130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. McCormack and T. J. Gonda
Novel murine myeloid cell lines that exhibit a differentiation switch in response to IL-3 or GM-CSF, or to different constitutively active mutants of the GM-CSF receptor beta subunit
Blood,
January 1, 2000;
95(1):
120 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Borg, M. Zhang, D. Hegge, R. L. Stephen, D. J. Buckley, N. S. Magnuson, and A. R. Buckley
Prolactin Regulation of pim-1 Expression: Positive and Negative Promoter Elements
Endocrinology,
December 1, 1999;
140(12):
5659 - 5668.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. J. Jenkins, F. Le, and T. J. Gonda
A Cell Type-specific Constitutive Point Mutant of the Common beta -Subunit of the Human Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF), Interleukin (IL)-3, and IL-5 Receptors Requires the GM-CSF Receptor alpha -Subunit for Activation
J. Biol. Chem.,
March 26, 1999;
274(13):
8669 - 8677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sakamoto, T. Kitamura, and A. Yoshimura
Mitogen-activated Protein Kinase Plays an Essential Role in the Erythropoietin-dependent Proliferation of CTLL-2 Cells
J. Biol. Chem.,
November 10, 2000;
275(46):
35857 - 35862.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |